Propel mometasone furoate implant (trade name
Propel), is a
bioabsorbable steroid-eluting stent developed by
Intersect ENT. It is implanted after surgery to assist in treating chronic rhinosinusitis. It delivers steroids over a 30 day period prior to dissolving, and has been shown to improve outcomes of surgery.